• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-9 的表达与预后相关,并参与卵巢癌细胞的侵袭。

Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.

机构信息

Department of Gynecology, The People's Hospital of Guangxi Province, Guangxi Medical University, Nanning, 530021, Guangxi, People's Republic of China.

出版信息

Arch Gynecol Obstet. 2012 Dec;286(6):1537-43. doi: 10.1007/s00404-012-2456-6. Epub 2012 Jul 26.

DOI:10.1007/s00404-012-2456-6
PMID:22832979
Abstract

PURPOSE

One of the most important characteristics of ovarian cancer is invasion and metastasis. Matrix metalloproteinases (MMPs) are known to play an important role in cancer cell invasion by mediating the degradation of extracellular matrix (ECM). The activities of MMPs are regulated by tissue inhibitors of metalloproteinases (TIMPs). In this study, we investigated the clinical significance of MMP-2, -7 and -9 and TIMP-1, -2 and -3 expression and MMP-9 functional role in cell invasion and adhesion in ovarian cancer.

METHODS

RT-PCR was used to determine mRNA expression of MMP-2, -7 and -9 and TIMP-1, -2 and -3 in ovarian tissues; ELISA was used to detect the serum level of MMP-9; RNA interference (RNAi) was performed to determine the function of MMP-9 in cell invasion and adhesion in ovarian cancer cells.

RESULTS

mRNA expression of MMP-2, MMP-7, MMP-9, TIMP-2 and TIMP-3 and serum level of MMP-9 were significantly high in patients with ovarian cancer. MMP-9 expression was significantly high in patients with advanced ovarian cancer and correlated with poor prognosis. The ability of cells for invasion and adhesion was significantly reduced by treatment of cells with MMP-9 siRNA.

CONCLUSIONS

Our results suggest that MMP-9 is a potential prognostic factor for ovarian cancer and could be a novel treatment target in ovarian cancer patients.

摘要

目的

卵巢癌最重要的特征之一是侵袭和转移。已知基质金属蛋白酶(MMPs)通过介导细胞外基质(ECM)的降解在癌细胞侵袭中发挥重要作用。MMPs 的活性受金属蛋白酶组织抑制剂(TIMPs)的调节。本研究旨在探讨 MMP-2、-7 和 -9 以及 TIMP-1、-2 和 -3 在卵巢癌中的表达及其在细胞侵袭和黏附中的功能作用的临床意义。

方法

采用 RT-PCR 法检测卵巢组织中 MMP-2、-7 和 -9 以及 TIMP-1、-2 和 -3 的 mRNA 表达;采用 ELISA 法检测 MMP-9 的血清水平;采用 RNA 干扰(RNAi)法确定 MMP-9 在卵巢癌细胞侵袭和黏附中的功能。

结果

卵巢癌患者的 MMP-2、MMP-7、MMP-9、TIMP-2 和 TIMP-3 的 mRNA 表达以及 MMP-9 的血清水平均显著升高。晚期卵巢癌患者 MMP-9 表达水平较高,与预后不良相关。用 MMP-9 siRNA 处理细胞可显著降低细胞的侵袭和黏附能力。

结论

本研究结果表明,MMP-9 可能是卵巢癌的一个潜在预后因子,也可能成为卵巢癌患者的一个新的治疗靶点。

相似文献

1
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.基质金属蛋白酶-9 的表达与预后相关,并参与卵巢癌细胞的侵袭。
Arch Gynecol Obstet. 2012 Dec;286(6):1537-43. doi: 10.1007/s00404-012-2456-6. Epub 2012 Jul 26.
2
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].[基质金属蛋白酶-9、2、7及金属蛋白酶组织抑制剂-1、2、3 mRNA在卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2004 Oct;23(10):1194-8.
3
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.基质金属蛋白酶(MMP - 2、MMP - 9、MT1 - MMP)及其抑制剂(TIMP - 1、TIMP - 2)在卵巢常见上皮性肿瘤中的表达
Int J Oncol. 2000 Oct;17(4):673-81.
4
[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].基质金属蛋白酶-2、基质金属蛋白酶-9、金属蛋白酶组织抑制因子-1及金属蛋白酶组织抑制因子-2在乳腺癌中的表达及临床意义
Ai Zheng. 2003 Sep;22(9):968-73.
5
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.结直肠癌组织样本中基质金属蛋白酶2和7(MMP - 2、MMP - 7)以及基质金属蛋白酶组织抑制剂1和2(TIMP - 1、TIMP - 2)的定量测定
Anticancer Res. 2005 Sep-Oct;25(5):3387-91.
6
[Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].[基质金属蛋白酶及其组织抑制剂在肝细胞癌中的表达]
Hunan Yi Ke Da Xue Xue Bao. 2003 Jun;28(3):212-6.
7
Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.三氧化二砷(As₂O₃)在体外和体内均可抑制卵巢癌细胞的腹膜侵袭。
Gynecol Oncol. 2006 Oct;103(1):199-206. doi: 10.1016/j.ygyno.2006.02.037. Epub 2006 Apr 19.
8
Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor.卵巢肿瘤中的明胶酶及其组织抑制剂;TIMP-1是一个预测性及预后性因素。
Gynecol Oncol. 2005 Dec;99(3):656-63. doi: 10.1016/j.ygyno.2005.07.009. Epub 2005 Aug 19.
9
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.乳腺癌组织中基质金属蛋白酶及其抑制剂的表达。
Breast. 2013 Jun;22(3):330-4. doi: 10.1016/j.breast.2012.08.002. Epub 2012 Sep 18.
10
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.基质金属蛋白酶及其组织抑制剂在子宫内膜癌中的表达以及基质金属蛋白酶-7表达与预后的相关性
Int J Mol Med. 2005 Oct;16(4):541-6.

引用本文的文献

1
Targeting circulating tumor cell‒neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis.靶向循环肿瘤细胞与中性粒细胞的相互作用:抑制癌症转移的纳米工程策略
J Nanobiotechnology. 2025 Jun 17;23(1):449. doi: 10.1186/s12951-025-03522-8.
2
Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities.白细胞介素-6是塑造卵巢癌炎症性肿瘤微环境以及通过诊断和预后效用确定其热或冷性质的关键因素。
Cancers (Basel). 2025 May 17;17(10):1691. doi: 10.3390/cancers17101691.
3
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence.
胰高血糖素样肽1受体激动剂与癌症风险:通过机制理解和临床证据推动精准医学发展
Biomark Res. 2025 Mar 27;13(1):50. doi: 10.1186/s40364-025-00765-3.
4
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in -Mutated Epithelial Ovarian Cancer Cell Lines.奥拉帕利联合DDR抑制剂可有效预防上皮性卵巢癌细胞系中的EMT并影响miRNA调控。
Int J Mol Sci. 2025 Jan 15;26(2):693. doi: 10.3390/ijms26020693.
5
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies.卵巢癌中白细胞介素-6的调节需要靶向策略:从获批疗法到新兴疗法
Cancers (Basel). 2024 Dec 16;16(24):4187. doi: 10.3390/cancers16244187.
6
Intricate relationship between cancer stemness, metastasis, and drug resistance.癌症干性、转移和耐药性之间的复杂关系。
MedComm (2020). 2024 Sep 21;5(10):e710. doi: 10.1002/mco2.710. eCollection 2024 Oct.
7
Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer.某些基质金属蛋白酶(MMP-2、MMP-3、MMP-11、MMP-26)、HE4、CA125 及 ROMA 算法在卵巢癌诊断中的应用价值。
Int J Mol Sci. 2024 Jun 6;25(11):6265. doi: 10.3390/ijms25116265.
8
Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.组织金属蛋白酶抑制剂 3:揭示其在肿瘤学中的生物学功能和意义。
Int J Mol Sci. 2024 Mar 10;25(6):3191. doi: 10.3390/ijms25063191.
9
Comparative analysis between highgrade serous ovarian cancer and healthy ovarian tissues using single-cell RNA sequencing.使用单细胞RNA测序对高级别浆液性卵巢癌与健康卵巢组织进行比较分析。
Front Oncol. 2023 Apr 14;13:1148628. doi: 10.3389/fonc.2023.1148628. eCollection 2023.
10
Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer.上皮性卵巢癌液体活检中潜在miRNA生物标志物的代谢途径
Oncol Lett. 2023 Feb 23;25(4):142. doi: 10.3892/ol.2023.13728. eCollection 2023 Apr.